Cosmix molecular biologicals GmbH, Opsonic, Tripep deal

Newco Opsonic received exclusive, worldwide licenses to Tripep's redirecting antibody specificity ( RAS) technology and Cosmix's mRNA display library technology to identify target-binding peptides to ...